News

  1. Premier Research & InSilicoTrials Leverage Silico Modeling, Simulation, & Optimize Regulatory Pathways For Rare Disease Therapies 3/13/2023
  2. Premier Research And CENTOGENE Launch Strategic Partnership To Accelerate And De-Risk Rare Disease Clinical Development 1/12/2023
  3. Premier Research Names Jennifer Nezzer Vice President Of Biometrics 9/29/2021
  4. Premier Research Deepens Support For Oncology Sponsors By Expanding Oncology Leadership Team 8/27/2021
  5. Premier Research Names Stefan Schnydrig Chief Human Resources Officer 8/27/2021
  6. Premier Research Launches PremierPredict™ Trial Enrollment Simulator for More Accurate & Efficient Study Start-Up 7/29/2021

    Premier Research, a leading provider of clinical research and development and advisory services to the biotechnology, specialty pharma, and medical device industry, today announced the launch of PremierPredict™, a powerful clinical trial enrollment probability simulator.

  7. Premier Research Acquires Specialty Women's Health and Diagnostics CRO 7/29/2021

    Premier Research today announced that it has acquired Health Decisions, a Durham, N.C.-based contract research organization (CRO) focused on clinical development in all areas of women’s health and diagnostics.

  8. Premier Research Renews Sponsorship For World Orphan Drug Congress Europe 11/8/2019

    Premier Research is proud to once again be a sponsor of the World Orphan Drug Congress (WODC) Europe taking place November 12-14, 2019, in Barcelona, Spain. As part of our ongoing support for this innovative conference, Jonathan Kornstein, Executive Director, Program Strategy, Rare Disease & Pediatrics, will present a session entitled "A Partnership That Lasts: Key Considerations When Working With CROs on Rare Disease Studies."

  9. Premier Research Champions Patient Advocacy Community 2/28/2019

    As part of its commitment to supporting the patient advocacy community and as a kickoff to Rare Disease Day on February 28 and March as Rare Disease Month, clinical research company Premier Research is announcing both a new scholarship for rare disease patient advocates in partnership with Professional Patient Advocates in Life Sciences (PPALS) and the launch of a new Patient and Stakeholder Engagement (PASE) capability led by Juliet Moritz.